Quotient Bioresearch has reported how its multiplexed assays are delivering more data, on a greater number of analytes and in a shorter time.
Dr Craig Stovold, senior project manager - bioanalytical sciences at Quotient Bioresearch said this capability enables researchers to extract as much information as possible from each sample.
Stovold was speaking at the recent Biomarker World Congress 2009, held in Philadelphia, US, on 27-29 May.
The increasing importance of biomarkers poses a number of challenges for the analytical laboratory.
A large panel of biomarkers is often required to fully characterise a disease state and drug efficacy for a given condition.
Ethical considerations and the requirements for clinical safety testing may impose practical limits on the number of samples that can be collected.
